Citation Impact
Citing Papers
Anti-C5 Antibody Treatment Ameliorates Weakness in Experimentally Acquired Myasthenia Gravis
2007
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
The UK Biobank resource with deep phenotyping and genomic data
2018 StandoutNature
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody
2018
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans
2005
Updated Role of Nitric Oxide in Disorders of Erythrocyte Function
2013
Complement and its role in innate and adaptive immune responses
2009 Standout
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
2007
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Complement, a target for therapy in inflammatory and degenerative diseases
2015
Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria
2007
Innate immunity in diabetic kidney disease
2020
Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice
2010
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Guillain-Barré syndrome
2016 Standout
Mesenchymal stem cells in health and disease
2008 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
COVID-19: A review of therapeutic strategies and vaccine candidates
2020
Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
2012
The role of complement in antibody-mediated rejection in kidney transplantation
2012
Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro
2010
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model
2008
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Guillain–Barré Syndrome
2012 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Pre-emptive Eculizumab and Plasmapheresis for Renal Transplant in Atypical Hemolytic Uremic Syndrome
2011
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
2012
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Paroxysmal Nocturnal Hemoglobinuria from Bench to Bedside
2011
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Role of the Skin Biopsy in the Diagnosis of Atypical Hemolytic Uremic Syndrome
2015
Acute tubular necrosis is characterized by activation of the alternative pathway of complement
2005
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Paroxysmal nocturnal haemoglobinuria presenting as cerebral venous sinus thrombosis
2008
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
2020 StandoutNobel
Systemic Lupus Erythematosus
2011 Standout
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
2013
Age-related macular degeneration
2018 Standout
How were new medicines discovered?
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
Sickle-cell disease
2010 Standout
The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection
2008
An open label clinical trial of complement inhibition in multifocal motor neuropathy
2011
Complement and coagulation: strangers or partners in crime?
2007
mRNA transcript therapy
2014 StandoutNobel
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Taking Complement to the Clinic – has the Time Finally Come?
2009
Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction
2009
Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment
2009
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
2011
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
2006
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion
2011
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Extraocular Muscle Susceptibility to Myasthenia Gravis
2008
Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia
2015
Salivating for Knowledge: Potential Pharmacological Agents in Tick Saliva
2008
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Validating therapeutic targets through human genetics
2013
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation–Associated Thrombotic Microangiopathy
2013
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death
2015 Standout
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Rituximab-Associated Infections
2010
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Intracellular Protein Delivery System with Protein Needle–GFP Construct
2014 StandoutNobel
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease
2018
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent
2021 StandoutNobel
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Update on the diagnosis and treatment of Pneumocystis pneumonia
2010
How I treat acquired aplastic anemia
2012
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Complement System Part II: Role in Immunity
2015
Cytokine Storm
2020 Standout
DNA Cleavage within theMLLBreakpoint Cluster Region Is a Specific Event Which Occurs as Part of Higher-Order Chromatin Fragmentation during the Initial Stages of Apoptosis
1997
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Degos Disease
2011
Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides
2018 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Targeting the complement system in bacterial meningitis
2019
Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents
2008
Rheumatoid arthritis and the complement system
2007
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
2008
Opposing Regulatory Roles of Complement Factor 5 in the Development of Bleomycin-Induced Pulmonary Fibrosis
2005
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development
2017
Hidden Killers: Human Fungal Infections
2012 Standout
Direct acute tubular damage contributes to Shigatoxin‐mediated kidney failure
2014
Cold agglutinin disease
2016
Works of Modupe Elebute being referenced
Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology
2006
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
2006
Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow
2002
Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria
2004
PLATINUM AGENTS AND SECONDARY MYELOID LEUKAEMIA: TWO CASES TREATED ONLY WITH PLATINUM‐BASED DRUGS
1996
Prospective Phase II Pilot Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline) with Ciclosporin for Patients with Acquired Aplastic Anemia and Matched Pair Analysis with Patients Treated with Horse ATG (Lymphoglobuline) and Ciclosporin: A Study From the EBMT Severe Aplastic Anemia Working Party (RATGAA07)
2011
Treatment with the Terminal Complement Inhibitor Eculizumab Improves Anemia in Patients with Paroxysmal Nocturnal Hemoglobinuria: Phase III Triumph Study Results.
2006
Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
2013